International Rx Shortages Summit Urges New Purchasing Models
This article was originally published in PharmAsia News
Value of continuous supply should be factor in reimbursement decisions, an International Pharmaceutical Federation report suggests.
You may also be interested in...
The heavily concentrated sterile injectable manufacturing industry is creating roadblocks to the success of the Accelerated Recovery Initiative; GPhA predicts crisis will linger for years to come.
Five-point plan that calls for FDA to change definition of ‘labeling’ and ‘substantial evidence’ may offer hints as to what the next iteration of 21st Century Cures legislation will offer.
Breast cancer meeting highlights challenges of patient-focused drug development as breast cancer patients ask for trials to better identify characteristics of super-responders so patients can make more informed risk-benefit decisions.